Add new attachment

Only authorized users are allowed to upload new attachments.

This page (revision-8) was last changed on 24-Dec-2012 10:31 by 1614216108

This page was created on 16-Apr-2012 13:39 by UnknownAuthor

Only authorized users are allowed to rename pages.

Only authorized users are allowed to delete pages.

Difference between version and

At line 4 changed one line
  英文名称:tissue plasminogen activator,t-PA\\
  英文名称:[Plasminogen activator tissue type]\\
At line 6 changed one line
包括组织型纤溶酶原激活物(t-PA:A)检测和抗原含量(t-PA:Ag)检测。组织纤溶酶原激活物是一种单链糖蛋白,主要由血管内皮细胞合成、分泌、不断释放入血液,广泛存在于机体的各种组织内,肝脏是组织纤溶酶原激活物灭活的主要场所。它对纤维蛋白有高度的亲和力,然后将酪氨酸纤溶酶原形成纤溶酶,降解纤维蛋白(原)和部分凝血因子,是纤溶系统的关键物质。\\
  包括组织型纤溶酶原激活物(t-PA:A)检测和抗原含量(t-PA:Ag)检测。组织纤溶酶原激活物是一种单链糖蛋白,主要由血管内皮细胞合成、分泌、不断释放入血液,广泛存在于机体的各种组织内,肝脏是组织纤溶酶原激活物灭活的主要场所。它对纤维蛋白有高度的亲和力,然后将酪氨酸纤溶酶原形成纤溶酶,降解纤维蛋白(原)和部分凝血因子,是纤溶系统的关键物质。\\
At line 11 added one line
  溶栓治疗监测:静脉注射t-PA 10~20分钟后,血浆t-PA:A或t-PA:Ag达到参考范围上限的2~3倍时可取得较好疗效。
At line 13 changed one line
  参考范围:血浆t-PA:A0.3~0.6活化单位/ml(发色底物法),血浆t-PA:Ag 1~12 g/L。\\
  血浆t-PA:A0.3~0.6活化单位/ml(发色底物法),血浆t-PA:Ag 1~12 g/L。\\
  免疫学法1~12μg/l或4.0±1.8μg/l;生物学法0.17±0.01IU/ml。(该数据来源于现代实验诊断学-检验与临床第二版,刘人伟、翁心植编)
At line 15 removed 6 lines
%%tab-医学决定水平
/%
%%tab-危急值范围
/%
%%tab-方法学评价
/%
At line 18 added one line
  避免精神刺激和体力活动,安静10分钟后抽血。
At line 21 added 3 lines
标本采集:3.2%枸橼酸钠0.2ml抗凝,不用压脉带准确取静脉血1.8ml,或蓝帽真空管静脉采血,3000r/min离心分离血浆。尽可能在24小时内测定。-20℃稳定3周,反复融冻不超过5次影响不大。\\
标本运送:采集后应立即送到实验室。
At line 26 added one line
[纤溶活性]
Version Date Modified Size Author Changes ... Change note
8 24-Dec-2012 10:31 0.862 kB 1614216108 to previous
7 24-Dec-2012 10:23 0.922 kB Administrator to previous | to last Tissue plasminogen activator,t-PA ==> Plasminogen activator tissue type
6 12-Jul-2012 15:25 0.888 kB 1614216108 to previous | to last
5 12-Jul-2012 15:25 0.697 kB 1614216108 to previous | to last
4 03-May-2012 13:32 0.72 kB 1614216108 to previous | to last
3 25-Apr-2012 15:26 0.712 kB 1614216108 to previous | to last
2 20-Apr-2012 16:57 0.687 kB 1614216108 to previous | to last
1 16-Apr-2012 13:39 0.611 kB UnknownAuthor to last
« This page (revision-8) was last changed on 24-Dec-2012 10:31 by 1614216108